A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature

Yabes, Joseph M.; Perdikis, Serafim; Graham, David B.; Markelz, Ana

doi:10.1186/s12879-018-3414-0

Table 1 Reported cases of Aerococcus urinae endocarditis

From: A rare case of Aerococcus urinae infective endocarditis in an atypically young male: case report and review of the literature

Case No.	Age (yrs)	Sex	Risk Factors	Valve	Surgery (y/n)	Antibiotic Regimen	Duration	Survived(y/n)	Ref No.
1	69	M	Cystoscopy	Av	N	β Lactam/AG	6wks	Y	[13]
2	54	M	Phimosis	Mv	Y	β Lactam	6wks	Y	[32]
3	43	M	Hepatitis C	Av	N	β Lactam/AG	5 days	N	[19]
4	68	M	Indwelling Catheter	Av	Y	β Lactam/AG	6/2wks	Y	[29]
5	80	M	Malignancy	Av	Y	β Lactam	6wks	Y	[33]
6	77	M	BPH	Av	N	β Lactam/Van	–	N	[10]
7	68	M	BPH	Mv	N	β Lactam/AG; oral regimen	3wks; unknown	Y	[14]
8	75	M	Cystoscopy	Av	Y	β Lactam/AG	6wks	Y	[15]
9	89	M	TURP	Mv	N	β Lactam/AG	7 days	N	[16]
10	81	M	UTI	Av	N	β Lactam/AG	2wks/8da	N	[34]
11	42	M	None	Av	Y	β Lactam/AG	6wks	Y	[18]
12	49	M	–	Av	–	β Lactam/AG	–	Y	[35]
13	54	M	Urethral Stricture	T/Av	N	β Lactam/AG	–	N	[36]
14	69	M	Malignancy	Av	Y	β Lactam	12wks	Y	[17]
15	62	M	BPH	M/Av	Y	β Lactam/Rif, AG	6wks, AG 2wks	Y	[25]
16	78	M	Aortic stenosis	Av	N	β Lactam/AG	10 days	N	[26]
17	74	M	BPH	Mv	Y	β Lactam/AG	4wks	N	[11]
18	81	M	BPH	Mv	N	β Lactam/AG	6wks	Y	[12]
19	78	M	Indwelling Catheter	Av	N	β Lactam	–	N	[12]
20	87	M	BPH	Mv	N	–	–	N	[12]
21	78	F	Ureteral Stent	Av	N	β Lactam/Van	2wks	N	[12]
22	48	M	ASD	Mv	N	β Lactam/AG	–	Y	[27]
23	79	F	UTI	Av	N	β Lactam	6wks	Y	[27]
24	91	M	Indwelling Catheter	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
25	91	M	BPH	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
26	89	F	–	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
27	86	M	Urethral Stricture	Av	–	β Lactam/AG	4wks/10d^b	Y	[5]
28	83	M	Urethral Stricture	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
29	80	F	–	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
30	77	M	–	Av	–	β Lactam/AG	4wks/10d^b	Y	[5]
31	75	M	BPH	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
32	74	M	Suprapubic Catheter	–	–	β Lactam/AG	4wks/10d^b	Y	[5]
33	65	M	Indwelling Catheter	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
34	53	M	Dysuria	Av	–	β Lactam/AG	4wks/10d^b	Y	[5]
35	49	F	Intermittent Catheter	Av	–	β Lactam/AG	4wks/10d^b	Y	[5]
36	81	M	Indwelling Catheter	Mv	–	β Lactam/AG	4wks/10d^b	Y	[5]
37	74	F	Malignancy	–	–	β Lactam/AG	4wks/10d^b	Y	[5]
38	87	M	Malignancy	Mv	–	β Lactam/AG	–	N	[9]
39	77	M	Liver Failure	Av	–	β Lactam/AG	–	Y	[9]
40	83	M	Indwelling Catheter	Mv	–	β Lactam/AG	–	Y	[9]
41	73	M	Suprapubic Catheter	–	–	β Lactam/AG	–	N	[9]
42	88	F	Aortic Stenosis	Av	–	β Lactam/AG	–	Y	[9]
43	43	M	Indwelling Catheter	Mv	Y	β Lactam/AG	6wks	Y	^a

β Lactam/AG Beta-Lactam/Aminoglycoside, Van-vancomycin, BPH benign prostatic hyperplasia; ASD Atrial septal defect, TURP trans-urethral prostate biopsy, UTI urinary tract infection, ^aThis paper, ^bMedian Duration of therapy for each agent

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Infectious Diseases

Contact us